Natera CEO Steven Chapman Sells Shares Worth $545,000
On September 1, 2026, Natera's CEO and President, Steven Leonard Chapman, sold 1,698 shares of common stock for a total value of $545,000. The transaction was conducted under an amended Rule 10b5-1 trading plan established in March 2026 to ensure compliance with insider trading regulations. Following the sale, Chapman retained ownership of 98,199 shares directly and holds derivative securities that maintain his economic exposure to Natera's performance. His remaining stake represents approximately 0.06% of the company’s total equity. The stock price at the time was $320.99 per share. Natera operates in the molecular diagnostics sector with a market capitalization of $52.1 billion and trailing twelve-month revenue of $2.7 billion, despite reporting net losses during that period.
Tickers: $NTRA
Topics: Rule 10b5-1 plan SEC filing stock sale